Baidu
map

内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

ADA 关于糖尿病合并高血压的最新立场声明的解读

2017-10-30 中国循证医学杂志.2017.17(10):1117-1120.

糖尿病高血压

高血压是动脉粥样硬化性心血管疾病（atherosclersosis cardiovascular disease，ASCVD）、心力衰竭、微血管并发症的高危因素。糖尿病合并高血压较为常见，美国糖尿病学会（American Diabetes Association，ADA）在近日发布立场声明，更新了对糖尿病合并高血压的治疗和评估。为借鉴 ADA 对糖尿病合并高血压患者的降压治疗方法，本文对其立场声明

中文标题：

ADA 关于糖尿病合并高血压的最新立场声明的解读

发布机构：

发布日期：

2017-10-30

简要介绍：

高血压是动脉粥样硬化性心血管疾病（atherosclersosis cardiovascular disease，ASCVD）、心力衰竭、微血管并发症的高危因素。糖尿病合并高血压较为常见，美国糖尿病学会（American Diabetes Association，ADA）在近日发布立场声明，更新了对糖尿病合并高血压的治疗和评估。为借鉴 ADA 对糖尿病合并高血压患者的降压治疗方法，本文对其立场声明进行解读和评价，以帮助中国医生在实践中更好地理解和参考相关指南推荐。

作者： 四川大学华西医院内分泌代谢病科 刘钰琪 邓丽莎,成都市龙泉驿区第一人民医院内分泌科 童南伟

 

拓展指南：与糖尿病相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=ADA 关于糖尿病合并高血压的最新立场声明的解读)] GetToolGuiderByIdResponse(projectId=1, id=3aad31c00151809e, title=ADA 关于糖尿病合并高血压的最新立场声明的解读, enTitle=, guiderFrom=中国循证医学杂志.2017.17(10):1117-1120., authorId=null, author=, summary=高血压是动脉粥样硬化性心血管疾病（atherosclersosis cardiovascular disease，ASCVD）、心力衰竭、微血管并发症的高危因素。糖尿病合并高血压较为常见，美国糖尿病学会（American Diabetes Association，ADA）在近日发布立场声明，更新了对糖尿病合并高血压的治疗和评估。为借鉴 ADA 对糖尿病合并高血压患者的降压治疗方法，本文对其立场声明, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Mon Oct 30 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>高血压是动脉粥样硬化性心血管疾病（atherosclersosis cardiovascular disease，ASCVD）、心力衰竭、微血管并发症的高危因素。糖尿病合并高血压较为常见，美国糖尿病学会（American Diabetes Association，ADA）在近日发布立场声明，更新了对糖尿病合并高血压的治疗和评估。为借鉴 ADA 对糖尿病合并高血压患者的降压治疗方法，本文对其立场声明进行解读和评价，以帮助中国医生在实践中更好地理解和参考相关指南推荐。 </P>作者： 四川大学华西医院内分泌代谢病科 刘钰琪 邓丽莎,成都市龙泉驿区第一人民医院内分泌科 童南伟 <P> </P>拓展指南：<strong>与<font color=red>糖尿病</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=5d0d21c00151830e" title="2017年ACP《2型糖尿病口服药物治疗临床实践指南》解读" target=_blank>2017年ACP《2型糖尿病口服药物治疗临床实践指南》解读</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=3aad31c00151809e" title="ADA 关于糖尿病合并高血压的最新立场声明的解读" target=_blank>ADA 关于糖尿病合并高血压的最新立场声明的解读</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=44b6f1c00151a1a2" title="2017 VA/DoD临床实践指南：2型糖尿病的管理" target=_blank>2017 VA/DoD临床实践指南：2型糖尿病的管理</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=45b691c00151334f" title="2017 KDA立场声明：降糖药物治疗成人2型糖尿病" target=_blank>2017 KDA立场声明：降糖药物治疗成人2型糖尿病</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=699c41c001512ec9" title="2017 KDA立场声明：成人2型糖尿病患者胰岛素治疗" target=_blank>2017 KDA立场声明：成人2型糖尿病患者胰岛素治疗</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E7%B3%96%E5%B0%BF%E7%97%85" target=_blank>有关糖尿病更多指南</a></ul>, tagList=[TagDto(tagId=216, tagName=糖尿病), TagDto(tagId=274, tagName=高血压)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5676, appHits=432, showAppHits=0, pcHits=3397, showPcHits=2293, likes=175, shares=10, comments=5, approvalStatus=1, publishedTime=Sat Nov 11 18:37:47 CST 2017, publishedTimeString=2017-10-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Nov 11 18:37:47 CST 2017, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 11:36:58 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=ADA 关于糖尿病合并高血压的最新立场声明的解读)])
ADA 关于糖尿病合并高血压的最新立场声明的解读
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=264271, encodeId=8dde2642e127, content=好好看下.内容丰富, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Nov 25 21:10:34 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262279, encodeId=01df2622e90b, content=谢谢分享知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Nov 18 13:26:20 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260996, encodeId=059d2609967c, content=讲解的非常好,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Nov 13 13:20:11 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260623, encodeId=2cf926062388, content=高血压是动脉粥样硬化性心血管疾病(atherosclersosis cardiovascular disease.ASCVD).心力衰竭.微血管并发症的高危因素.糖尿病合并高血压较为常见.美国糖尿病学会(American Diabetes Association.ADA)在近日发布立场声明.更新了对糖尿病合并高血压的治疗和评估, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Nov 11 23:22:25 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260607, encodeId=de5726060e15, content=很好的文章.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sat Nov 11 22:49:15 CST 2017, time=2017-11-11, status=1, ipAttribution=)]
    2017-11-25 虈亣靌

    好好看下.内容丰富

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=264271, encodeId=8dde2642e127, content=好好看下.内容丰富, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Nov 25 21:10:34 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262279, encodeId=01df2622e90b, content=谢谢分享知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Nov 18 13:26:20 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260996, encodeId=059d2609967c, content=讲解的非常好,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Nov 13 13:20:11 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260623, encodeId=2cf926062388, content=高血压是动脉粥样硬化性心血管疾病(atherosclersosis cardiovascular disease.ASCVD).心力衰竭.微血管并发症的高危因素.糖尿病合并高血压较为常见.美国糖尿病学会(American Diabetes Association.ADA)在近日发布立场声明.更新了对糖尿病合并高血压的治疗和评估, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Nov 11 23:22:25 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260607, encodeId=de5726060e15, content=很好的文章.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sat Nov 11 22:49:15 CST 2017, time=2017-11-11, status=1, ipAttribution=)]
    2017-11-18 虈亣靌

    谢谢分享知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=264271, encodeId=8dde2642e127, content=好好看下.内容丰富, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Nov 25 21:10:34 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262279, encodeId=01df2622e90b, content=谢谢分享知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Nov 18 13:26:20 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260996, encodeId=059d2609967c, content=讲解的非常好,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Nov 13 13:20:11 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260623, encodeId=2cf926062388, content=高血压是动脉粥样硬化性心血管疾病(atherosclersosis cardiovascular disease.ASCVD).心力衰竭.微血管并发症的高危因素.糖尿病合并高血压较为常见.美国糖尿病学会(American Diabetes Association.ADA)在近日发布立场声明.更新了对糖尿病合并高血压的治疗和评估, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Nov 11 23:22:25 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260607, encodeId=de5726060e15, content=很好的文章.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sat Nov 11 22:49:15 CST 2017, time=2017-11-11, status=1, ipAttribution=)]
    2017-11-13 虈亣靌

    讲解的非常好,值得学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=264271, encodeId=8dde2642e127, content=好好看下.内容丰富, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Nov 25 21:10:34 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262279, encodeId=01df2622e90b, content=谢谢分享知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Nov 18 13:26:20 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260996, encodeId=059d2609967c, content=讲解的非常好,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Nov 13 13:20:11 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260623, encodeId=2cf926062388, content=高血压是动脉粥样硬化性心血管疾病(atherosclersosis cardiovascular disease.ASCVD).心力衰竭.微血管并发症的高危因素.糖尿病合并高血压较为常见.美国糖尿病学会(American Diabetes Association.ADA)在近日发布立场声明.更新了对糖尿病合并高血压的治疗和评估, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Nov 11 23:22:25 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260607, encodeId=de5726060e15, content=很好的文章.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sat Nov 11 22:49:15 CST 2017, time=2017-11-11, status=1, ipAttribution=)]
    2017-11-11 有备才能无患

    高血压是动脉粥样硬化性心血管疾病(atherosclersosis cardiovascular disease.ASCVD).心力衰竭.微血管并发症的高危因素.糖尿病合并高血压较为常见.美国糖尿病学会(American Diabetes Association.ADA)在近日发布立场声明.更新了对糖尿病合并高血压的治疗和评估

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=264271, encodeId=8dde2642e127, content=好好看下.内容丰富, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Nov 25 21:10:34 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262279, encodeId=01df2622e90b, content=谢谢分享知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Nov 18 13:26:20 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260996, encodeId=059d2609967c, content=讲解的非常好,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Nov 13 13:20:11 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260623, encodeId=2cf926062388, content=高血压是动脉粥样硬化性心血管疾病(atherosclersosis cardiovascular disease.ASCVD).心力衰竭.微血管并发症的高危因素.糖尿病合并高血压较为常见.美国糖尿病学会(American Diabetes Association.ADA)在近日发布立场声明.更新了对糖尿病合并高血压的治疗和评估, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Nov 11 23:22:25 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260607, encodeId=de5726060e15, content=很好的文章.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sat Nov 11 22:49:15 CST 2017, time=2017-11-11, status=1, ipAttribution=)]
    2017-11-11 清风拂面

    很好的文章.谢谢分享

    0

相关指南

糖尿病患者血糖波动管理专家共识

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2017-09-15

格列喹酮临床应用中国专家共识（2017年版）

中国医师协会内分泌代谢医师协会分会 · 2017-05-30

2017 SED/SERV共识指南：糖尿病视网膜病变的诊断和治疗（更新版）

西班牙糖尿病学会(SED,Spanish Society of Diabetes) · 2017-06-14

中国糖尿病药物注射技术指南（2016年版）

中华糖尿病杂志指南与共识编写委员会 · 2017-02-20

2016共识声明：患有糖尿病和慢性肾病患者应用抗糖尿病药物的剂量调整

国外内分泌相关专家小组（统称） · 2016-10-01

2017 ACOG实践简报：妊娠期糖尿病（No.180）

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2017-06-30

Baidu
map
Baidu
map
Baidu
map